Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) Dendrimers
- 26 April 2008
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 25 (7), 1723-1729
- https://doi.org/10.1007/s11095-008-9572-9
Abstract
Purpose To investigate potential application of poly(amidoamine) (PAMAM) dendrimers for improving the delivery of SN-38. Methods Complexes of SN-38 with generation 4 amine terminated PAMAM dendrimers were synthesized with varying amounts of drug. Stability of the complexes as well as influence of complexation on permeability across and cellular uptake by Caco-2 cells was evaluated. Results The complexes were stable at pH 7.4 and drug was released at pH 5. A tenfold increase in permeability and more than hundredfold increase in cellular uptake of the complexes with respect to free SN-38 was observed. Conclusions Studies suggest that complexation with PAMAM dendrimers has the potential to improve the oral bioavailability of SN-38.Keywords
This publication has 27 references indexed in Scilit:
- Influence of molecular architecture of polyether-co-polyester dendrimers on the encapsulation and release of methotrexateBiomaterials, 2007
- Varying polymer architecture to deliver drugsThe AAPS Journal, 2007
- Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cellsJournal of Controlled Release, 2006
- Polymer conjugates as anticancer nanomedicinesNature Reviews Cancer, 2006
- Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complexAdvanced Drug Delivery Reviews, 2005
- Excited-State Proton Transfer Reactions of 10-Hydroxycamptothecin1Journal of the American Chemical Society, 2004
- Influence of Surface Chemistry of Poly(Amidoamine) Dendrimers on Caco-2 Cell MonolayersJournal of Bioactive and Compatible Polymers, 2003
- CamptothecinsDrugs, 2002
- Unusual pH-Dependent Polarity Changes in PAMAM Dendrimers: Evidence for pH-Responsive Conformational ChangesMacromolecules, 2000
- Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming unitsAnti-Cancer Drugs, 1994